PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.\', \'German Center for Cardiovascular Research DZHK, Partner Site Rhine-Main, Berlin, Germany.\', \'Cardiopulmonary Institute, Goethe University Frankfurt, Frankfurt, Germany.\', \'Department of Internal Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.\', \'Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.\', \'Internal Medicine II, Department of Infectious Diseases, Freiburg University Hospital, Freiburg, Germany.\', \'Institute for Cardiovascular Regeneration, Goethe University Frankfurt, Frankfurt, Germany.\', \'Institute of Medical Virology, University of Frankfurt, Frankfurt, Germany.\', \'Department of Internal Medicine II, Technical University of Munich, Hospital rechts der Isar, Munich, Germany.\', \'University Hospital Regensburg, Regensburg, Germany.\', \'Department of Infectious Diseases, University Hospital Essen, Essen, Germany.\', \'Department of Internal Medicine I, Hospital Bremen-Mitte, Bremen, Germany.\', \'Department of Internal Medicine II, Giessen University, Giessen, Germany.\', \'Department of Internal Medicine II, Jena University, Jena, Germany.\', \'University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, University of Bochum, Minden, Germany.\', \'Department of Internal Medicine I, Hospital Passau, Passau, Germany.\', \'Department of Emergency and Intensive Care Medicine, Klinikum Ernst von Bergmann, Potsdam, Germany.\', \'Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'Department of Infectious Diseases and Infection Control, Ingolstadt Hospital, Ingolstadt, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0258684
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34673795
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all